Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis

RATIONALE & OBJECTIVE: Focal segmental glomerulosclerosis (FSGS) is a rare condition that can lead to kidney function decline and chronic kidney failure. Immunosuppressants are used to treat primary FSGS. However, their efficacy and safety in FSGS are not clearly established. We assessed current...

Descripción completa

Detalles Bibliográficos
Autores principales: Caster, Dawn J., Magalhaes, Barbara, Pennese, Natali, Zaffalon, Andrea, Faiella, Marina, Campbell, Kirk N., Radhakrishnan, Jai, Tesar, Vladmir, Trachtman, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399559/
https://www.ncbi.nlm.nih.gov/pubmed/36032548
http://dx.doi.org/10.1016/j.xkme.2022.100501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399559/
https://www.ncbi.nlm.nih.gov/pubmed/36032548
http://dx.doi.org/10.1016/j.xkme.2022.100501

Ejemplares similares